Given the reported tumor suppressor properties of PP2A [14], we have determined the impact of Arl2 on tumor cell aggressivity and tumorigenic capacity in two breast cancer cell models, MCF7 and MDA-MB-231. Here, PTPA is linked to breast carcinoma.